Literature DB >> 17173003

Back pain exacerbations and lost productive time costs in United States workers.

Judith A Ricci1, Walter F Stewart, Elsbeth Chee, Carol Leotta, Kathleen Foley, Marc C Hochberg.   

Abstract

STUDY
DESIGN: Cross-sectional with follow-up case-control component.
OBJECTIVES: To measure the prevalence of back pain (BP) and back pain exacerbations, describe BP features and functional impairment, estimate BP-related lost productive time (LPT) and costs, and assess the relation between pain exacerbations and lost productive time. SUMMARY OF BACKGROUND DATA: BP is associated with substantial lost work time. However, little is known about the extent to which BP with or without exacerbation explains lost work time.
METHODS: A national telephone survey of the U.S. workforce identified 320 workers 40 to 65 years of age with BP defined by NHANES I criteria and 91 matched non-BP controls. Participants self-reported pain characteristics, lost productive time (absenteeism and presenteeism) in the previous 2 weeks, activity limitations, and demographics. A population-weighting adjustment was applied to estimates to account for selection bias and ensure that estimates of certain sample demographic subgroups' totals conformed to the Current Population Survey.
RESULTS: The 2-week period prevalence of BP was 15.1%; 42% of workers with BP experienced pain exacerbations. BP prevalence was associated with demographic factors, but BP exacerbations were not. BP was reported by 42.6% of all workers. Workers with exacerbations reported more days with BP than those without exacerbations. Workers with exacerbations were significantly more likely than those without such exacerbations to report activity limitation (88.4% vs. 60.7%; P < 0.0001) and BP-related LPT (22.1% vs. 13.0%; P = 0.0259). BP in workers 40 to 65 years of age costs employers an estimated $7.4 billion/year. Workers with BP exacerbations account for 71.6% of this cost.
CONCLUSIONS: Workers with BP exacerbations account for a disproportionate share of the cost of BP-related lost productive time.

Entities:  

Mesh:

Year:  2006        PMID: 17173003     DOI: 10.1097/01.brs.0000249521.61813.aa

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  67 in total

1.  A systematic review and meta-analysis of efficacy, cost-effectiveness, and safety of selected complementary and alternative medicine for neck and low-back pain.

Authors:  Andrea D Furlan; Fatemeh Yazdi; Alexander Tsertsvadze; Anita Gross; Maurits Van Tulder; Lina Santaguida; Joel Gagnier; Carlo Ammendolia; Trish Dryden; Steve Doucette; Becky Skidmore; Raymond Daniel; Thomas Ostermann; Sophia Tsouros
Journal:  Evid Based Complement Alternat Med       Date:  2011-11-24       Impact factor: 2.629

Review 2.  Opioids for chronic noncancer pain: a new Canadian practice guideline.

Authors:  Andrea D Furlan; Rhoda Reardon; Clarence Weppler
Journal:  CMAJ       Date:  2010-05-03       Impact factor: 8.262

3.  Biomechanical, psychosocial and individual risk factors predicting low back functional impairment among furniture distribution employees.

Authors:  Sue A Ferguson; W Gary Allread; Deborah L Burr; Catherine Heaney; William S Marras
Journal:  Clin Biomech (Bristol, Avon)       Date:  2011-09-28       Impact factor: 2.063

4.  Distressed, immobilized, or lacking employer support? A sub-classification of acute work-related low back pain.

Authors:  Silje Endresen Reme; William S Shaw; Ivan A Steenstra; Mary Jane Woiszwillo; Glenn Pransky; Steven J Linton
Journal:  J Occup Rehabil       Date:  2012-12

Review 5.  The effects of quality of care on costs: a conceptual framework.

Authors:  Teryl K Nuckols; José J Escarce; Steven M Asch
Journal:  Milbank Q       Date:  2013-06       Impact factor: 4.911

6.  The role of prism glass and postural restoration in managing a collegiate baseball player with bilateral sacroiliac joint dysfunction: a case report.

Authors:  Jason H Robey; Kyndall Boyle
Journal:  Int J Sports Phys Ther       Date:  2013-10

7.  Exploring the prevalence and construct validity of high-impact chronic pain across chronic low-back pain study samples.

Authors:  Patricia M Herman; Nicholas Broten; Tara A Lavelle; Melony E Sorbero; Ian D Coulter
Journal:  Spine J       Date:  2019-03-15       Impact factor: 4.166

8.  Great trochanter bursitis vs sciatica, a diagnostic-anatomic trap: differential diagnosis and brief review of the literature.

Authors:  Aristeidis H Zibis; Vasileios D Mitrousias; Michail E Klontzas; Theofilos Karachalios; Sokratis E Varitimidis; Apostolos H Karantanas; Dimitrios L Arvanitis
Journal:  Eur Spine J       Date:  2018-02-01       Impact factor: 3.134

Review 9.  Organ culture bioreactors--platforms to study human intervertebral disc degeneration and regenerative therapy.

Authors:  Benjamin Gantenbein; Svenja Illien-Jünger; Samantha C W Chan; Jochen Walser; Lisbet Haglund; Stephen J Ferguson; James C Iatridis; Sibylle Grad
Journal:  Curr Stem Cell Res Ther       Date:  2015       Impact factor: 3.828

10.  Spine and pain clinics serving North Carolina patients with back and neck pain: what do they do, and are they multidisciplinary?

Authors:  Liana D Castel; Janet K Freburger; George M Holmes; Rachael P Scheinman; Anne M Jackman; Timothy S Carey
Journal:  Spine (Phila Pa 1976)       Date:  2009-03-15       Impact factor: 3.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.